Daraxonrasib (RMC-6236) is an effective targeted therapy for RAS-mutant neuroblastoma
Authors:
- Ronald D. HillRHRonald D. Hill
- Krista M. DaltonKDKrista M. Dalton
- Richard KurupiRKRichard Kurupi
- Yanli XingYXYanli Xing
- Jamie M. SlaughterJSJamie M. Slaughter
- Jane RobertsJRJane Roberts
- Victor A. KehindeVKVictor A. Kehinde
- Kun ZhangKZKun Zhang
- Bin HuBHBin Hu
- Li WangLWLi Wang
- Vita KraskauskieneVKVita Kraskauskiene
- Madelyn R. LorenzMLMadelyn R. Lorenz
Open Access
- 16 November 2026
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics